In-vitro evaluation of Cefiderocol and Ceftazidime/Avibactam against MDR and XDR gram-negative pathogens from clinical isolates, with whole genome sequencing-based analysis of Antimicrobial Resistance Genes in Cefiderocol-resistant Escherichia coli
- 22 May 2026
- journal article
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 62, 101154
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Aztreonam plus ceftazidime/avibactam broth disk elution test: failure to detect Escherichia coli with PBP-3 insertionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2026
- Evaluation of aztreonam/avibactam gradient test strip and aztreonam-ceftazidime/avibactam broth disk elution method for susceptibility testing of metallo-β-lactamase positive carbapenemase-producing bacteriaDiagnostic Microbiology and Infectious Disease, 2025
- In-vitro susceptibility of cefiderocol and other comparators in carbapenem-resistant Gram-negative bacilli: A study from IndiaIndian Journal of Medical Microbiology, 2025
- Cefiderocol susceptibility endows hope in treating carbapenem-resistant Pseudomonas aeruginosa : insights from in vitro and in silico evidenceRSC Advances, 2024
- In-vitro approaches for cefiderocol susceptibility testing and interpretation in the context of recent Clinical & Laboratory Standards Institute advisoryIndian Journal of Medical Microbiology, 2024
- In vitro activity of the newly approved antimicrobial agent Cefiderocol against Carbapenem resistant Gram negative clinical isolatesIndian Journal of Medical Microbiology, 2024
- An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam ResistanceOpen Forum Infectious Diseases, 2023
- Cefiderocol as Salvage Therapy for Carbapenem-Resistant Klebsiella pneumoniae Sepsis in an Extremely Preterm NeonateIndian Journal of Pediatrics, 2023
- Phenotypic synergy testing of ceftazidime–avibactam with aztreonam in a university hospital having high number of metallobetalactamase producing bacteriaInfectious Diseases, 2020
- Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patientsClinical Microbiology and Infection, 2019